BEAM - Beam Therapeutics GAAP EPS of -$1.33 in-line revenue of $24.2M beats by $8.56M May, 10 2023 08:47 AM Beam Therapeutics Inc. 2023-05-10 08:47:10 ET Beam Therapeutics press release ( NASDAQ: BEAM ): Q1 GAAP EPS of -$1.33 in-line. Revenue of $24.2M (+187.1% Y/Y) beats by $8.56M . For further details see: Beam Therapeutics GAAP EPS of -$1.33 in-line, revenue of $24.2M beats by $8.56M